JAZZ Annual Long Term Debt
$5.17 B
-$597.97 M-10.37%
31 December 2023
Summary:
As of January 22, 2025, JAZZ annual long term debt is $5.17 billion, with the most recent change of -$597.97 million (-10.37%) on December 31, 2023. During the last 3 years, it has risen by +$3.18 billion (+159.85%). JAZZ annual long term debt is now -15.38% below its all-time high of $6.11 billion, reached on December 31, 2021.JAZZ Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Quarterly Long Term Debt
$6.15 B
+$983.32 M+19.02%
30 September 2024
Summary:
As of January 22, 2025, JAZZ quarterly long term debt is $6.15 billion, with the most recent change of +$983.32 million (+19.02%) on September 30, 2024. Over the past year, it has increased by +$979.27 million (+18.93%). JAZZ quarterly long term debt is now -7.43% below its all-time high of $6.65 billion, reached on June 30, 2021.JAZZ Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.4% | +18.9% |
| 3 y3 years | +159.8% | +18.9% |
| 5 y5 years | +230.6% | +18.9% |
JAZZ Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.4% | at low | at high | +19.2% |
| 5 y | 5-year | -15.4% | +199.5% | -7.4% | +256.8% |
| alltime | all time | -15.4% | >+9999.0% | -7.4% | >+9999.0% |
Jazz Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.15 B(+19.0%) |
| June 2024 | - | $5.17 B(+0.1%) |
| Mar 2024 | - | $5.16 B(-0.1%) |
| Dec 2023 | $5.17 B(-10.4%) | $5.17 B(-0.1%) |
| Sept 2023 | - | $5.17 B(-10.1%) |
| June 2023 | - | $5.75 B(-0.2%) |
| Mar 2023 | - | $5.76 B(-0.1%) |
| Dec 2022 | $5.77 B(-5.6%) | $5.77 B(-0.1%) |
| Sept 2022 | - | $5.77 B(-4.9%) |
| June 2022 | - | $6.07 B(-0.1%) |
| Mar 2022 | - | $6.08 B(-0.5%) |
| Dec 2021 | $6.11 B(+207.1%) | $6.11 B(-3.6%) |
| Sept 2021 | - | $6.34 B(-4.7%) |
| June 2021 | - | $6.65 B(+234.1%) |
| Mar 2021 | - | $1.99 B(+0.0%) |
| Dec 2020 | $1.99 B(+15.3%) | $1.99 B(+0.1%) |
| Sept 2020 | - | $1.99 B(-10.3%) |
| June 2020 | - | $2.21 B(+28.4%) |
| Mar 2020 | - | $1.72 B(-0.1%) |
| Dec 2019 | $1.73 B(+10.4%) | $1.73 B(+0.1%) |
| Sept 2019 | - | $1.72 B(+0.0%) |
| June 2019 | - | $1.72 B(+0.3%) |
| Mar 2019 | - | $1.72 B(+10.0%) |
| Dec 2018 | $1.56 B(+1.5%) | $1.56 B(+0.2%) |
| Sept 2018 | - | $1.56 B(+0.1%) |
| June 2018 | - | $1.56 B(+1.4%) |
| Mar 2018 | - | $1.54 B(-0.2%) |
| Dec 2017 | $1.54 B(-22.7%) | $1.54 B(-0.2%) |
| Sept 2017 | - | $1.54 B(-5.6%) |
| June 2017 | - | $1.64 B(-6.0%) |
| Mar 2017 | - | $1.74 B(-12.7%) |
| Dec 2016 | $1.99 B | $1.99 B(-7.2%) |
| Sept 2016 | - | $2.15 B(+88.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $1.14 B(-0.4%) |
| Mar 2016 | - | $1.15 B(-0.4%) |
| Dec 2015 | $1.15 B(-13.7%) | $1.15 B(-1.8%) |
| Sept 2015 | - | $1.17 B(-12.4%) |
| June 2015 | - | $1.34 B(+0.2%) |
| Mar 2015 | - | $1.33 B(+0.1%) |
| Dec 2014 | $1.33 B(+144.9%) | $1.33 B(+0.1%) |
| Sept 2014 | - | $1.33 B(+12.2%) |
| June 2014 | - | $1.19 B(-0.2%) |
| Mar 2014 | - | $1.19 B(+118.4%) |
| Dec 2013 | $544.40 M(+27.5%) | $544.40 M(-0.2%) |
| Sept 2013 | - | $545.56 M(-0.2%) |
| June 2013 | - | $546.72 M(+30.6%) |
| Mar 2013 | - | $418.51 M(-2.0%) |
| Dec 2012 | $427.07 M(+1634.0%) | $427.07 M(-2.0%) |
| Sept 2012 | - | $435.63 M(-1.9%) |
| June 2012 | - | $444.19 M(+2059.5%) |
| Mar 2011 | - | $20.57 M(-16.5%) |
| Dec 2010 | $24.63 M(-73.0%) | $24.63 M(-24.7%) |
| June 2010 | - | $32.69 M(-59.0%) |
| Mar 2010 | - | $79.82 M(-12.4%) |
| Dec 2009 | $91.11 M(+21.3%) | $91.11 M(-21.0%) |
| Sept 2009 | - | $115.36 M(+0.5%) |
| June 2009 | - | $114.84 M(+977.5%) |
| Mar 2009 | - | $10.66 M(-90.6%) |
| Sept 2008 | - | $113.61 M(-0.1%) |
| June 2008 | - | $113.70 M(+0.3%) |
| Mar 2008 | - | $113.37 M(+50.9%) |
| Dec 2007 | $75.12 M(+1.1%) | $75.12 M(+0.3%) |
| Sept 2007 | - | $74.86 M(+0.3%) |
| June 2007 | - | $74.62 M(+0.3%) |
| Mar 2007 | - | $74.43 M(+0.2%) |
| Dec 2006 | $74.28 M(+0.9%) | $74.28 M(+0.9%) |
| Dec 2005 | $73.63 M | $73.63 M |
FAQ
- What is Jazz Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual long term debt year-on-year change?
- What is Jazz Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly long term debt year-on-year change?
What is Jazz Pharmaceuticals annual long term debt?
The current annual long term debt of JAZZ is $5.17 B
What is the all time high annual long term debt for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual long term debt is $6.11 B
What is Jazz Pharmaceuticals annual long term debt year-on-year change?
Over the past year, JAZZ annual long term debt has changed by -$597.97 M (-10.37%)
What is Jazz Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of JAZZ is $6.15 B
What is the all time high quarterly long term debt for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly long term debt is $6.65 B
What is Jazz Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, JAZZ quarterly long term debt has changed by +$979.27 M (+18.93%)